文献
J-GLOBAL ID:202002243248825795
整理番号:20A2460168
ペメトレキセドベース化学療法は甲状腺転写因子1(TTF-1)陰性,EGFR/ALK陰性肺腺癌におけるペメトレキセドフリーレジメンに下がる:傾向スコアマッチドペア分析【JST・京大機械翻訳】
Pemetrexed-Based Chemotherapy Is Inferior to Pemetrexed-Free Regimens in Thyroid Transcription Factor 1 (TTF-1)-Negative, EGFR/ALK-Negative Lung Adenocarcinoma: A Propensity Score Matched Pairs Analysis
著者 (13件):
Frost Nikolaj
(Department of Infectious Diseases and Respiratory Medicine, Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Berlin, Germany)
,
Zhamurashvili Tamar
(Department of Infectious Diseases and Respiratory Medicine, Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Berlin, Germany)
,
von Laffert Maximilian
(Department of Pathology, Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Berlin, Germany)
,
Klauschen Frederick
(Department of Pathology, Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Berlin, Germany)
,
Ruwwe-Glosenkamp Christoph
(Department of Infectious Diseases and Respiratory Medicine, Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Berlin, Germany)
,
Raspe Matthias
(Department of Infectious Diseases and Respiratory Medicine, Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Berlin, Germany)
,
Brunn Matthias
(Hospital Konigin-Elisabeth-Herzberge, Berlin, Germany)
,
Ochsenreither Sebastian
(Department of Hematology, Oncology, and Tumor Immunology, Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Berlin, Germany)
,
Temmesfeld-Wollbrueck Bettina
(Department of Infectious Diseases and Respiratory Medicine, Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Berlin, Germany)
,
Suttorp Norbert
(Department of Infectious Diseases and Respiratory Medicine, Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Berlin, Germany)
,
Grohe Christian
(Klinik fuer Pneumologie, Evangelische Lungenklinik Berlin Buch, Berlin, Germany)
,
Witzenrath Martin
(Department of Infectious Diseases and Respiratory Medicine, Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Berlin, Germany)
,
Witzenrath Martin
(Division of Pulmonary Inflammation, Charite-Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt-Universitaet zu Berlin, and Berlin Institute of Health, Berlin, Germany)
資料名:
Clinical Lung Cancer
(Clinical Lung Cancer)
巻:
21
号:
6
ページ:
e607-e621
発行年:
2020年
JST資料番号:
W3210A
ISSN:
1525-7304
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)